Mural Oncology
Biotechnology Research • 
Waltham, Massachusetts, United States • 51-100 Employees
Company overview
| Headquarters | 852 Winter St, Waltham, Massachusetts 02451, US |
| Website | |
| NAICS | 541714 |
| Keywords | Drug Discovery, Immuno-Oncology, Immunotherapy, Cancer, Ovarian Cancer, Protein Engineering, Interleukin-12, Cytokine Biology, Cytokine Therapies, Immune Cell Modulation, Interleukin-18, Mucosal Melanoma, Nemvaleukin, Nemvaleukin Alfa, Platinum-Resistant Ovarian Cancer, Proinflammatory Cytokines |
| Founded | 2023 |
| Employees | 51-100 |
| Socials |
Key Contacts at Mural Oncology
Anthony Macpherson
Senior Director, Development And External Quality
Dave Damrau
Executive Director, Clinical Trial Management
Rosh Varughese
Director, Clinical Data Management
James Leary
Senior Director, External Operations & Supply Chain
Muhammad Arshad Chaudhry
Associate Director, Process Development
Sachiyo Minegishi
Independent Director And Audit Chair
Leah Rider
Medical Director, Medical Affairs
Deepal Patel
Associate Director, Quality Control
Sam Theodoss
Sr. Director, Facilities At Mural Oncology, Inc.
Serena Honeycutt
Director, Accounting
Mural Oncology Email Formats
Mural Oncology uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@muraloncology.com), used 65.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@muraloncology.com | 65.1% |
{first name}.{last name} | john.doe@muraloncology.com | 34.9% |
About Mural Oncology
We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients’ lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)
Mural Oncology revenue & valuation
| Annual revenue | $4,534,415 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $14,600,000 |
| Total funding | $275,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Mural Oncology has 33 employees across 8 departments.
Departments
Number of employees
Mural Oncology Tech Stack
Discover the technologies and tools that power Mural Oncology's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
UI frameworks
WordPress plugins
JavaScript libraries
CDN
JavaScript libraries
Webmail
Miscellaneous
Security
Programming languages
United Kingdom
Netherlands
United Arab Emirates
Frequently asked questions
4.8
40,000 users
